News

GlobalData on MSN7h
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
WKTV NewsChannel 22h
FDA Greenlights First Blood Test to Help Diagnose Alzheimer’s Disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
Richmond Times-Dispatch4h
FDA OKs first blood test that can help diagnose Alzheimer's disease
The test can aid doctors in determining whether a patient's memory problems are due to Alzheimer's or a number of other ...
BioSpace4h
FDA Clears First Alzheimer’s Blood Test, Lending ‘Momentum’ to Lilly’s Kisunla, Biogen’s Leqembi
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
STAT2h
Some scientists are getting their NIH research dollars back
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
FDA clears 1st blood test to help diagnose Alzheimer's disease
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
The American Journal of Managed Care1h
FDA Clears First Blood Test for Early Detection of Alzheimer-Linked Amyloid Plaques
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
India Today on MSN5h
US FDA approves first blood test to diagnose Alzheimer's disease
The US FDA has approved the first blood test to detect Alzheimer's disease in its early stages. This advancement promises ...